Immuno-Oncology Trial Implementation — Where to start?
The rapid advancements in immuno-oncology therapies in recent years have transformed the clinical research landscape, but much remains uncertain about the operational hurdles that this therapeutic area presents.
Join KCR for a free live webinar lead by Anna Baran, KCR’s Chief Medical Officer, for insight on the successful planning and implementation of Immuno-Oncology trials!
Title: Immuno-Oncology Trial Implementation
Date: Tuesday, November 19, 2019
Time: 3.00 PM EST (NA), 8.00 PM GMT (UK)
Duration: 60 min (including Q&A session)
Presenter: Anna Baran, Chief Medical Officer, KCR
Location: Webex, link provided after registering
KCR, as a clinical development solutions provider, has successfully supported our clients in worldwide I-O trial planning and implementation. During this webinar, Dr. Anna Baran will present insights and key take-aways from these experiences to help facilitate future program design and to contribute the discussion on the ever-evolving world of Immuno-oncology.
Dr. Anna Baran will share the following:
o The methodology and assessment of competitive trial landscape using data-driven decision making
o An analysis of patient populations and epidemiology needed for I-O study design
o Cumulative experience and recent trends while authorizing early phase IO trials worldwide
o The need for site-level expertise on early detection and management of immune-related adverse events
The webinar is for all clinical and science professionals who are interested in immuno-oncology trial implementation.
To register, please contact Molly Garrity, KCR, at molly.garrity@kcrcro.com or +1–857–753–7853 by November 18th, 2019 with your contact details. Upon receiving the registering request, you will be provided with the link to Webex to join the webinar live.
Reserve your seat now! We are looking forward to welcoming you at our webinar!
